Medical Ikkou Group Income Statement

Financials in millions JPY. Fiscal year is March - February.

Millions JPY. Fiscal year is Mar - Feb.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 28, 2026	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022
Revenue	54,982	48,393	39,900	33,897	33,595
Revenue Growth (YoY)	13.62%	21.29%	17.71%	0.90%	6.30%
Cost of Revenue	48,497	42,649	35,349	30,715	29,982
Gross Profit	6,485	5,744	4,551	3,182	3,613
Selling, General & Admin	4,697	3,620	2,544	1,713	1,765
Amortization of Goodwill & Intangibles	-	138	171	209	242
Other Operating Expenses	-	290	277	325	331
Operating Expenses	4,697	4,052	2,992	2,247	2,338
Operating Income	1,788	1,692	1,559	935	1,275
Interest Expense	-102	-63	-54	-50	-58
Interest & Investment Income	100	72	47	39	30
Other Non Operating Income (Expenses)	173	114	198	301	110
EBT Excluding Unusual Items	1,959	1,815	1,750	1,225	1,357
Gain (Loss) on Sale of Investments	169	117	167	36	106
Gain (Loss) on Sale of Assets	4	77	-2	20	28
Asset Writedown	-65	-208	-256	-36	-10
Other Unusual Items	-43	99	2	67	-5
Pretax Income	2,024	1,900	1,661	1,312	1,476
Income Tax Expense	710	754	581	540	607
Earnings From Continuing Operations	1,314	1,146	1,080	772	869
Minority Interest in Earnings	-39	-13	-41	-13	-17
Net Income	1,275	1,133	1,039	759	852
Net Income to Common	1,275	1,133	1,039	759	852
Net Income Growth	12.53%	9.05%	36.89%	-10.91%	1.91%
Shares Outstanding (Basic)	4	4	4	4	4
Shares Outstanding (Diluted)	4	4	4	4	4
Shares Change (YoY)	0.10%	0.07%	0.03%	0.02%	-0.45%
EPS (Basic)	338.72	301.31	276.50	202.04	226.83
EPS (Diluted)	338.72	301.31	276.50	202.04	226.83
EPS Growth	12.41%	8.97%	36.85%	-10.93%	2.37%
Free Cash Flow	220	202	3,975	996	813
Free Cash Flow Per Share	58.45	53.72	1057.83	265.13	216.45
Dividend Per Share	-	60.000	45.000	40.000	40.000
Dividend Growth	-	33.33%	12.50%	-	-50.00%
Gross Margin	11.79%	11.87%	11.41%	9.39%	10.76%
Operating Margin	3.25%	3.50%	3.91%	2.76%	3.79%
Profit Margin	2.32%	2.34%	2.60%	2.24%	2.54%
Free Cash Flow Margin	0.40%	0.42%	9.96%	2.94%	2.42%
EBITDA	2,631	2,454	2,342	1,776	2,145
EBITDA Margin	4.78%	5.07%	5.87%	5.24%	6.39%
D&A For EBITDA	843	762	783	841	870
EBIT	1,788	1,692	1,559	935	1,275
EBIT Margin	3.25%	3.50%	3.91%	2.76%	3.79%
Effective Tax Rate	35.08%	39.68%	34.98%	41.16%	41.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.